Phase 1 Keratoconus Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking

Bacterial KeratitisEctasia of CorneaKeratoconus, Unstable

Pacific Clear Vision Institute300 enrolled1 locationNCT03918408

Recruiting

Phase 1Phase 2

Safety and Efficacy of Corneal Cross-linking in Subjects With Keratoconus

Progressive Keratoconus

Glaukos Corporation150 enrolled3 locationsNCT05314738